Drugs designed to treat castration-resistant tumours are also facing a resistance problem -20-40% of patients do not respond to these therapies, and their efficacy is eventually lost in all men (see page S128).
Therapies for advanced prostate cancer have emerged only in the past decade. The go-to treatment is chemical castration: drugs are used to suppress male hormones. This can prolong life by two or three years before tumours become resistant.
Once prostate cancer has spread to the lymph nodes and bones, the outlook is poor. Five-year survival rates for metastatic cancer are one-third of those for localized disease; advanced prostate cancer is considered incurable.
Can advanced prostate cancer be treated?
The challenge facing active surveillance is knowing which men have slow-growing tumours that can be left, and which are more aggressive. New methods for telling aggressive and indolent cancer cells apart are being investigated.
Half of US men with low-risk prostate cancer between 2010 and 2013 had their prostates removed, whereas 40% opted to watch and wait. Some studies have suggested that low-risk patients can be safely monitored for more than a decade.
The most common treatments for localized disease -removal of the prostate and radiotherapy -have side effects, such as incontinence and sexual dysfunction. Men with less-aggressive tumours might be better off avoiding these procedures.
Is it safe to leave prostate cancer alone?
The PSA test could be a useful procedure if it is applied using evidence-based guidelines (page S123). Combining the screen with other analyses, such as testing for genetic markers, could reduce the number of unnecessary treatments.
Rates of diagnosis spiked in the 1990s in the United States, partly because of the use of PSA screening for men without symptoms. But it is likely that many men were unnecessarily treated for cancers that would never have caused harm.
Measuring levels of PSA in the blood is often used to detect prostate cancer. Without a reliable test, in some cases, the first symptoms of the cancer are signs that it has spread to the bones, where it is much less treatable.
Is PSA testing an effective method of screening?
Taking into account the differing rates of prostate-specific antigen (PSA) testing in populations could help to firm up links. Arsenic and cadmium compounds, anabolic steroids and ionizing radiation may be causes; carrots and soya may reduce the risk. 
